MDT and patient perspectives on GLP-1 RA therapy and emerging incretin-based dual agonists in T2D and obesity
touchPODCAST

MDT and patient perspectives on GLP-1 RA therapy and emerging incretin-based dual agonists in T2D and obesity

2022-03-11
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient explore the use of GLP-1 RA therapy to treat T2D and obesity, including observations from a patient’s perspective, and consider the evidence for incretin-based dual agonists in development The multidisciplinary team and patient Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA Patient: Ms B...
View more
Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free